The prognostic value of cardiopulmonary exercise testing in idiopathic pulmonary fibrosis

K. Flaherty (Ann Arbour, United States of America)

Source: Annual Congress 2011 - The prognostic value of cardiopulmonary exercise testing
Session: The prognostic value of cardiopulmonary exercise testing
Session type: Symposium
Number: 1852
Disease area: Interstitial lung diseases

Slide presentationMultimedia files

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. Flaherty (Ann Arbour, United States of America). The prognostic value of cardiopulmonary exercise testing in idiopathic pulmonary fibrosis. Annual Congress 2011 - The prognostic value of cardiopulmonary exercise testing

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Cardiopulmonary exercise test as prognostic tool in patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2007 - Considerations in the management of idiopathic pulmonary fibrosis and other interstitial lung diseases
Year: 2007


The prognostic significance of cardiopulmonary exercise in IPF
Source: Annual Congress 2011 - What is new in the approach to pulmonary fibrosis?
Year: 2011

Relationship of cardiopulmonary exercise testing (CPET) and lung function in idiopathic pulmonary fibrosis (IPF)
Source: Eur Respir J 2007; 30: Suppl. 51, 120s
Year: 2007

Concurrent validity among three field tests and the cardiopulmonary exercise testing in patients with idiopathic pulmonary fibrosis.
Source: Virtual Congress 2020 – News on diagnosis and therapy of idiopathic pulmonary fibrosis
Year: 2020


The value of cardiopulmonary exercise test in assessment of the severity of pulmonary arterial hypertension patients
Source: International Congress 2017 – Exercise and physiology in pulmonary hypertension
Year: 2017

The role of cardiopulmonary exercise test in identifying pulmonary veno-occlusive disease
Source: Eur Respir J, 57 (6) 2100115; 10.1183/13993003.00115-2021
Year: 2021



The sPAP/VO2 ratio during cardiopulmonary exercise testing as predictor of manifest pulmonary hypertension
Source: Annual Congress 2012 - Pulmonary circulation: clinical end-points and clinical physiology
Year: 2012

Pulmonary function and cardiopulmonary exercise tests in patients with bronchiectasis
Source: Annual Congress 2010 - Exercise in healthy and non-respiratory diseases
Year: 2010

Cardiopulmonary exercise test to predict pulmonary rehabilitation outcome in chronic obstructive pulmonary disease (COPD)
Source: International Congress 2017 – Latest insights into functional capacity, muscle weakness and physical activity in chronic lung diseases
Year: 2017


Endurance time is the most sensitive exercise measurement for evaluating pulmonary rehabilitation efficacy in patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2012 - The latest insights in pulmonary rehabilitation
Year: 2012


Value of cardiopulmonary exercise testing in interstitial lung diseases
Source: International Congress 2018 – New methods and concepts in exercise testing
Year: 2018

Cardiopulmonary exercise testing in patients with severe pulmonary hypertension
Source: Eur Respir J 2001; 18: Suppl. 33, 489s
Year: 2001

Value of maximal and submaximal variables during incremental cardiopulmonary exercise testing to predict survival in pateints with pulmonary arterial hypertension (PAH)
Source: Annual Congress 2009 - Pulmonary circulation I
Year: 2009


The prognostic role of cardiopulmonary exercise testing in disease
Source: International Congress 2018 – PG16 Advanced cardiopulmonary exercise testing
Year: 2018


The prognostic role of cardiopulmonary exercise testing in disease
Source: International Congress 2019 – PG3 Advanced cardiopulmonary exercise testing
Year: 2019


Cardiopulmonary exercise testing in interstitial lung diseases and the value of ventilatory efficiency
Source: Eur Respir Rev, 30 (162) 200355; 10.1183/16000617.0355-2020
Year: 2021



Exercise testing to predict outcome in idiopathic versus associated pulmonary arterial hypertension
Source: Eur Respir J 2012; 40: 1410-1419
Year: 2012



The prognostic value of cardiopulmonary exercise testing in interstitial lung disease: a systematic review
Source: ERJ Open Res, 6 (3) 00027-2020; 10.1183/23120541.00027-2020
Year: 2020



Exertional dyspnoea in interstitial lung diseases: the clinical utility of cardiopulmonary exercise testing
Source: Eur Respir Rev 2017; 26: 160099
Year: 2017